
Volpara Health
@volpara
Volpara's groundbreaking breast health software - combined with empowered patients - will unleash a revolution in cancer detection (ASX: VHT).
ID: 459628279
https://volparahealth.com 09-01-2012 21:50:30
2,2K Tweet
1,1K Followers
1,1K Following



The University of Rochester is setting the bar high in mammography quality! 📈 Volpara Analytics™ helped them reduce technical repeat rates to as low as 1-2% and foster a culture of recognition and improvement among their 40+ technologists. volparahealth.com/news/customer-…

Between 2020–2023, nearly 26% of Rush University System for Health's patients were flagged as an elevated risk, enabling personalized surveillance with advanced imaging options like ABUS and Fast MRI. Learn how Rush uses our tech to ensure tailored care: volparahealth.com/news/customer-…

🚨 Lunit AI was highlighted yesterday during The Imaging Wire Show! Learn from UC Davis Health and Mosaic Breast Imaging as they share insights and their experience using Lunit Cancer Screening's AI technology to improve cancer detection. youtube.com/watch?v=Ybu0vM…


"Radiologists used to read images on their own?!" 😱 At RSNA, our CEO Teri Thomas spoke with @MedCityNews about how Volpara and Lunit Cancer Screening are shaping the future of mammography with AI—bringing smarter tools and sharper insights to radiology. medcitynews.com/2024/12/why-on…


Just got back from RSNA, and wow—it was a whirlwind! 🩷 This year marked a big milestone—our first event with Lunit Cancer Screening since joining forces. Together, we unveiled how our combined expertise will shape the future of breast cancer diagnostics. koreabiomed.com/news/articleVi…





In just 24 months, Singing River Health System achieved: ✔️ 25% of patients met NCCN Guidelines® for genetic testing. ✔️ 36% completed the test onsite, identifying 6% with pathogenic mutations or carrier status. ✔️ 42% received negative genetic results Learn more: volparahealth.com/news/customer-…

Over 25% of patients at Rush University Medical Center are flagged as high-risk for breast cancer—thanks to Volpara® Risk Pathways™. In just two years, 69% of high-risk patients met NCCN Guidelines® for follow-up, leading to improved outcomes. volparahealth.com/news/customer-…


Think your eyes can beat Lunit Cancer Screening? 🤔 Test yourself compared to Lunit INSIGHT for Breast via an interactive challenge experience. Let us know your results in the comments. 👇 insight-challenge.lunit.io

“The key is to help technologists not fear AI but to embrace it as a partner.” 💡 That’s how University of Rochester achieved its mammography quality goals across 12 imaging sites, a mobile van, and 40 technologists. Learn how: volparahealth.com/news/customer-…



Make 2025 the year you improve how you identify and manage high-risk patients. Rush University did: "We have a 56-year-old patient whose life was changed by understanding her risk and getting access to additional imagining beyond her annual mammogram." volparahealth.com/news/customer-…